The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The significance of protocol biopsy after intravesical BCG treatment in patients with non-muscle–invasive bladder cancer.
Satoru Maruyama
No relevant relationships to disclose
Nobuo Shinohara
No relevant relationships to disclose
Norihiro Murahashi
No relevant relationships to disclose
Hidetaka Suzuki
No relevant relationships to disclose
Ryuji Matsumoto
No relevant relationships to disclose
Tomoshige Akino
No relevant relationships to disclose
Naoto Miyajima
No relevant relationships to disclose
Kunihiko Tsuchiya
No relevant relationships to disclose
Takashige Abe
No relevant relationships to disclose
Katsuya Nonomura
No relevant relationships to disclose